Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101717320B details a green, one-pot Mannich base synthesis using water and liquid superacids. Discover cost-effective manufacturing and high-purity intermediates.
Patent CN104725174B reveals metal-free biaryl synthesis. Reduces metal waste and simplifies purification for pharmaceutical intermediates supply chain.
Patent CN102603570A reveals a novel one-step ionic liquid cyanation method. Achieve significant cost reduction in pharma intermediates manufacturing with high purity.
Patent CN112939798A reveals a green amidation route for amantadine using PIL-1, offering significant cost reduction and supply chain stability for pharmaceutical intermediates.
Novel CSA-catalyzed route offers high yield and room temperature operation for cost-effective pharmaceutical intermediate manufacturing and scalable production.
Novel chiral oxazoline palladium coordination compound patent CN105198935A offers high conversion in Henry reactions. Reliable supplier for pharmaceutical intermediates manufacturing.
Patent CN106928136A reveals graphene palladium cobalt catalyst for Montelukast intermediate. Enhances purity and supply chain reliability for pharmaceutical manufacturing.
Patent CN115739184B reveals a novel Rhodium catalyst for diisobutylene hydroformylation, offering high selectivity and supply chain stability for plasticizer intermediates.
Discover a safer, scalable preparation method for (3R,5R)-3,5-dihydroxy-6-cyanohexanoate. Enhance supply chain reliability and reduce manufacturing costs with our novel catalytic route.
Novel synthesis of Fludioxonil intermediate via o-cresol formylation and direct oxidation. Reduces cost and environmental risk for agrochemical manufacturing.
Patent CN104860897A reveals a novel Lewis acid catalyzed route for Hepatitis C intermediates. Achieve superior chiral purity and supply chain reliability with scalable manufacturing.
Patent CN101294176B details a glucose-based biotransformation route for L-ribose. This method offers high purity and environmental benefits for pharmaceutical intermediate supply chains.
Patent CN102503887B reveals a mild AgOTf-catalyzed route to isoquinolines. This method offers cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN115851863B reveals enzymatic route for spongane skeletons. Offers cost reduction and supply reliability for pharmaceutical intermediates manufacturing.
Novel NHC-catalyzed desymmetrization route for high-purity rolipram intermediates offering significant cost and supply chain advantages.
Patent CN109678900B reveals a high-yield ionic liquid catalyzed route for phosphonate sulfonamides, offering significant cost reduction in pharmaceutical manufacturing and superior activity against MRSA.
Novel Lewis acid catalyzed synthesis reduces reaction time significantly. High yield pharmaceutical intermediate production with scalable supply chain reliability for global partners.
Patent CN1775764A details a high-yield tetrazole synthesis using Yb(OTf)3. This method offers significant cost reduction in API manufacturing and improved supply chain reliability.
Patent CN105732518B reveals trisulfonate ionic liquid catalysis for pyrimidinone derivatives, offering biodegradable solutions and scalable manufacturing for pharmaceutical intermediates.
Advanced resin-catalyzed process for ganciclovir intermediates ensures high purity and scalable production for global pharmaceutical supply chains reducing costs.